Mettler ToledoMTDEarnings & Financial Report
Mettler Toledo, stylized in all caps, is a multinational supplier of precision instruments and services. The company focuses on laboratory, industrial, product inspection, and food retailing applications. Its products are used in research, quality control, and manufacturing processes in life sciences, food, chemical, and many other industries.
MTD Q4 2025 Key Financial Metrics
Revenue
$1.1B
Gross Profit
$675.4M
Operating Profit
N/A
Net Profit
$285.8M
Gross Margin
59.8%
Operating Margin
N/A
Net Margin
25.3%
YoY Growth
8.1%
EPS
$13.91
Financial Flow
Mettler Toledo Q4 2025 Financial Summary
Mettler Toledo reported revenue of $1.1B for Q4 2025, with a net profit of $285.8M (25.3% margin). Cost of goods sold was $454.3M, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $1.1B |
|---|---|
| Net Profit | $285.8M |
| Gross Margin | 59.8% |
| Operating Margin | N/A |
| Report Period | Q4 2025 |
Mettler Toledo Annual Revenue by Year
Mettler Toledo annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.0B).
| Year | Annual Revenue |
|---|---|
| 2025 | $4.0B |
| 2024 | $3.9B |
| 2023 | $3.8B |
| 2022 | $3.9B |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $925.9M | $946.8M | $954.5M | $1.05B | $883.7M | $983.2M | $1.03B | $1.13B |
| YoY Growth | -0.3% | -3.6% | 1.3% | 11.8% | -4.6% | 3.9% | 7.9% | 8.1% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $3.28B | $3.25B | $3.32B | $3.24B | $3.23B | $3.40B | $3.52B | $3.71B |
| Liabilities | $3.44B | $3.40B | $3.47B | $3.37B | $3.42B | $3.66B | $3.77B | $3.74B |
| Equity | $-158.7M | $-152.8M | $-154.4M | $-126.9M | $-182.0M | $-258.8M | $-249.2M | $-23.6M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $190.0M | $257.5M | $254.7M | $266.2M | $194.4M | $236.4M | $299.4M | $225.6M |
Other Health Care Companies
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
TECH
Bio-Techne
Revenue
$295.9M
Net Profit
$38.0M
CRL
Charles River Laboratories
Revenue
$994.2M
Net Profit
$-276.6M
DHR
Danaher Corporation
Revenue
$6.1B
Net Profit
$908.0M
IQV
IQVIA
Revenue
$4.4B
Net Profit
$514.0M
TMO
Thermo Fisher Scientific
Revenue
$11.1B
Net Profit
$1.6B
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B